Scott J. Dylla

Phenotypic characterization of human colorectal cancer stem cells

Piero Dalerba, Scott J. Dylla, In-Kyung Park et al. · Proceedings of the National Academy of Sciences · 2007 · 2.2K citations · Full text

Medicine, Cell Biology, Oncology +17

Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML

Catriona Jamieson, Laurie Ailles, Scott J. Dylla et al. · New England Journal of Medicine · 2004 · 1.5K citations · Full text

Life Sciences, Cell Biology, Hematology +17

Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

Scott J. Dylla, Lucia Beviglia, In‐Kyung Park et al. · PLoS ONE · 2008 · 582 citations · Full text

Medicine, Cell Biology, Oncology +17

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Laura R. Saunders, Alexander J. Bankovich, Wade Anderson et al. · Science Translational Medicine · 2015 · 578 citations

Medicine, Oncology, Pharmacology +17

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

Charles M. Rudin, M. Catherine Pietanza, Todd M. Bauer et al. · The Lancet Oncology · 2016 · 553 citations · Full text

Medicine, Oncology, Pharmacology +15